Deferred Tax Assets, Gross of KalVista Pharmaceuticals, Inc. from 31 Dec 2013 to 30 Apr 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
KalVista Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2013 to 30 Apr 2025.
  • KalVista Pharmaceuticals, Inc. Deferred Tax Assets, Gross for the quarter ending 30 Apr 2025 was $66,184,000, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $66,184,000 +$6,217,000 +10% 30 Apr 2025 10-K 10 Jul 2025 2025 FY
Q1 2024 $59,967,000 +$12,929,000 +27% 30 Apr 2024 10-K 10 Jul 2025 2025 FY
Q1 2023 $47,038,000 +$17,249,000 +58% 30 Apr 2023 10-K 11 Jul 2024 2024 FY
Q1 2022 $29,789,000 +$11,581,000 +64% 30 Apr 2022 10-K 10 Jul 2023 2023 FY
Q1 2021 $18,208,000 30 Apr 2021 10-K 07 Jul 2022 2022 FY
Q4 2015 $28,846,000 +$9,419,000 +48% 31 Dec 2015 10-K 30 Mar 2016 2015 FY
Q4 2014 $19,427,000 +$5,162,000 +36% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q4 2013 $14,265,000 31 Dec 2013 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.